Aberrant CpG island methylation in neurofibromas and neurofibrosarcomas

  • Authors: Pilar Gonzalez-Gomez, M. Josefa Bello, Dolores Arjona, M. Eva Alonso, Jesus Lomas, Jose M. De Campos, M. Elena Kusak, Manuel Gutierrez, Jose L. Sarasa, Juan A. Rey
  • View Affiliations

  • Published online on: Monday, September 1, 2003
  • Pages: 1519-1523
  • DOI: 10.3892/or.10.5.1519

Abstract

Aberrant methylation of the promoter CpG island of human genes is an alternative gene inactivation mechanism that contributes to the carcinogenesis of human tumours. We have determined the methylation status of the CpG island of 11 tumour-related genes (RB1, p14ARF, p16INK4a, p73, TIMP-3, MGMT, DAPK, THBS1, caspase 8, TP53 and GSTP1) in 18 neurofibromas (including one plexiform neurofibroma) and three neurofibrosarcomas, as well as two non-neoplastic peripheral nerve sheath samples, using methylation-specific polymerase chain reaction. The series included sporadic and neurofibromatosis type 1-associated tumours. The incidence of aberrant methylation in the tumour samples was 52% for THBS1, 43% for MGMT, 33% for TIMP-3, 19% each for p16INK4a and p73, 14% for RB1, 5% for p14ARF, and 0% for DAPK, caspase 8, TP53 and GSTP1. No methylation of these genes was detected in the two samples of non-neoplastic peripheral nerve sheath. All but three samples in the study displayed aberrant methylation in at least one of the studied genes, and there was no correlation between methylation status and the patients' clinical parameters. These findings suggest that methylation of some tumour-related genes may play a significant role in the tumourigenesis of neurofibromas/neurofibrosarcomas.
Journal Cover

September 2003
Volume 10 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

2012 Impact Factor: 2.297
Ranked #36/196 Oncology
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Gonzalez-Gomez, P., Bello, M., Arjona, D., Alonso, M., Lomas, J., De Campos, J., Kusak, M., Gutierrez, M., Sarasa, J., & Rey, J. (2003). Aberrant CpG island methylation in neurofibromas and neurofibrosarcomas. Oncology Reports, 10(5), 1519-1523.
MLA
Gonzalez-Gomez, Bello, Arjona, Alonso, Lomas, De Campos, Kusak, Gutierrez, Sarasa, and Juan Rey. "Aberrant CpG island methylation in neurofibromas and neurofibrosarcomas." Oncology Reports Oncology Reports 10.5 (2003): 1519-1523.
Chicago
Gonzalez-Gomez, Bello, Arjona, Alonso, Lomas, De Campos, Kusak, Gutierrez, Sarasa, and Juan Rey. "Aberrant CpG island methylation in neurofibromas and neurofibrosarcomas." Oncology Reports Oncology Reports 10 no. 5 (2003): 1519-1523.